about
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancerAn Overview of Genetic Changes and Risk of Pancreatic Ductal AdenocarcinomaMolecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.Targeting reactive nitrogen species suppresses hereditary pancreatic cancer.Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer.Elevated DNA damage response in pancreatic cancer.Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.Pancreatic cancer stromal biology and therapy.A concise review on the current understanding of pancreatic cancer stem cellsTherapeutic opportunities within the DNA damage response.Pancreatic cancer: current understanding of molecular and genetic aetiologies.Pancreatic cancer: BRCA mutation and personalized treatment.Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.IKBKE Is Required during KRAS-Induced Pancreatic Tumorigenesis.Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells.Pancreatic cancer actionable genes in precision medicine and personalized surgery.The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.Pancreatic Cancer Screening.Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An OverviewGermline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts
P2860
Q28066320-A9285F9B-626C-445B-83B9-D7CE7F3294E1Q28076342-6468B2D8-6E0E-4F2C-B58E-45DE4BEA8D7BQ33624574-D5ABF04F-CF22-48BF-9EAE-75B2C537F7EEQ33821218-2C9B24C5-E698-4CCF-B00B-ED5B24C8A39EQ33887034-8830B6B4-5639-47E9-B666-3A845F0B03F9Q34422252-FFBF78C1-1B26-403F-8AD1-BC2360C0B9D2Q34566631-89180628-F342-400B-B620-900497D3A1BBQ35671422-C0F05173-093C-46AC-BB47-AF6C493B7D1AQ35746569-B667323A-A999-4F00-9C83-338FA8EACED1Q35766799-77B37C2A-49EA-475F-B108-0EFA15D6E6ABQ35801362-7FB8E77F-0C30-461A-9F76-40BA1962EBD7Q38364665-8F33DCAE-65E2-41A7-B0E8-8951970CB82CQ38540431-A7228753-005A-49BE-8DB0-F9BFAFA4E22AQ38592167-CA2A907A-CD24-46AB-B696-75BEA37111C5Q38682057-05DAF307-3B7E-49B2-AB3B-AFC0F18C5517Q38722219-3C942DD6-6197-4D83-9651-6E476EA59390Q38874006-F4637627-DC33-4D85-B6F3-FED520682145Q38884916-CD60A4A2-78CA-4461-8653-25CB1ABDC08CQ39080898-C6B9F15A-2891-4D72-91F6-C73CEF850218Q39126045-77DB2E9D-1140-4DBD-8390-D920E8C5F23CQ48594379-4E81060B-B342-4032-BA00-8BD66B34629CQ57091632-85A2C844-4F8C-4EAE-B349-77BA77842BA9Q57165768-281C3F41-5CDF-471A-A842-4BDDA50D1113
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Familial pancreatic cancer: genetic advances.
@ast
Familial pancreatic cancer: genetic advances.
@en
Familial pancreatic cancer: genetic advances.
@nl
type
label
Familial pancreatic cancer: genetic advances.
@ast
Familial pancreatic cancer: genetic advances.
@en
Familial pancreatic cancer: genetic advances.
@nl
prefLabel
Familial pancreatic cancer: genetic advances.
@ast
Familial pancreatic cancer: genetic advances.
@en
Familial pancreatic cancer: genetic advances.
@nl
P2860
P356
P1433
P1476
Familial pancreatic cancer: genetic advances.
@en
P2093
Anil K Rustgi
P2860
P356
10.1101/GAD.228452.113
P577
2014-01-01T00:00:00Z